BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price hit a new 52-week high during trading on Monday . The stock traded as high as $1.80 and last traded at $1.77, with a volume of 40632 shares. The stock had previously closed at $1.75.
BioRestorative Therapies Trading Down 4.0 %
The company has a 50 day moving average of $1.60 and a 200 day moving average of $1.53. The firm has a market cap of $2.75 billion, a price-to-earnings ratio of -1.57 and a beta of 102.36.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Articles
- Five stocks we like better than BioRestorative Therapies
- Stock Splits, Do They Really Impact Investors?
- Real Estate Stock Signals a Boom in Manufacturing Activity
- Investing in large cap stocks: Diving into big caps
- This Medical Giant’s Stock Rebounds: A 15% Upside Is the Minimum
- Which Wall Street Analysts are the Most Accurate?
- Financial Giant’s Shares Soar on EPS Beat and Record Asset Levels
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.